Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications economic burden crohns disease europe findings systemic literature review
… from social media posts on the impact of alzheimer's disease on care partners. Frederiksen KS, Crawford R, … D, Comer M, Paulsen R, Hartry A, DiBenedetti D. Poster Economic burden of transitions to later stages of Alzheimer's disease …
… to Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple … disease associated with a significant humanistic and economic burden. While there is no cure for MS, disease-modifying …
… prevalence is higher in Parkinson’s and Alzheimer’s disease compared to other types of dementia. Antipsychotics … within the last 10 years. The main conclusions of our literature search are that: The majority of studies analyzing … and all included nonspecific codes. As a result of these findings, a validated coding algorithm updated to ICD-10 …
… Anne Heyes, MBA Vice President, Head of Value & Access, Europe RTI Health Solutions Sweeping Developments in Health … more large-molecule drugs or biologicals instead. On the disease-area level, companies might be thinking of … These Challenges? We support clients on portfolio and disease-area levels as well as with individual drugs in …
… M , Myers E, Diaz-Decaro J. Poster. Public health and economic impact of pediatric immunization program in Greece. … productivity losses associated with invasive meningococcal disease (IMD) in the United States (US). Shah H, …
… and fall short of public health goals. Given the human and economic burden of vaccine-preventable disease, understanding the factors behind these low coverage …
… Montreal, Canada. Transcript: Around 0.5% of women in Europe and 2% of women in the US use antiepileptic drugs … and have, ideally, a benign safety profile. We conducted a literature review to identify an appropriate reference antiepileptic …
… and evaluated the similarities and differences in Europe, North America, South America, Asia, and Oceania. The … a general process. In Europe, North America and Oceania, economic evaluations are incorporated into HTA reviews using … HTAs consider other economic elements beyond QALYs. HTA review times vary across and within regions. For example, in …
… Anne Heyes, MBA Vice President, Head of Value & Access , Europe RTI Health Solutions In this video, Anne discusses … more large-molecule drugs or biologicals instead. On the disease-area level, companies might be thinking of … these challenges? We support clients on portfolio and disease-area levels as well as with individual drugs in …
… of autoimmune disorders. Our experience includes: Celiac disease Immunoglobulin treatments Lupus erythematosus … budget Impact) Drug utilization studies Epidemiology of disease Measurement of patient preferences for treatment …